$ENVA

Vanguard Capital Management (ENVA) discloses 5.01% beneficial stake in Enova

Vanguard Capital Management and affiliates filed a Schedule 13G reporting beneficial ownership of 1,250,002 shares of Enova International Inc. common stock, or 5.01% of the outstanding class. The filing states sole voting power over 186,034 shares and sole dispositive power over 1,250,002 shares.

Original reporting
Published Jul 31, 2026, 2:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$ENVA
Neutral
low confidence
Mentioned
$ENVA
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

This provides transparency on who holds voting and dispositive power, but the filing summary does not describe activism, board involvement, or a specific catalyst.

02

Market read

The main tradable takeaway is the reported 5.01% beneficial ownership by Vanguard, which may affect positioning and monitoring, but lacks an explicit near-term catalyst.

03

What to watch

Traders should check whether the filing is 13G (passive) versus 13D (active intent) and look for subsequent amendments or other holders crossing thresholds.

Relevance 4/10Novelty 4/10Timing: filed/posted today, but it is a periodic ownership disclosure

Background

The text summarizes a Schedule 13G beneficial ownership filing by Vanguard Capital Management and affiliates for Enova International.

Company-level read

Ticker impact

$ENVANeutralLow confidence
Context

Vanguard Capital Management filed a Schedule 13G showing 1,250,002 shares, or 5.01% beneficial ownership, in Enova International.

Expected impact

Likely limited near-term impact; any move would be sentiment-driven unless paired with additional filings or corporate actions.

Evidence & confidence

The article is a routine Schedule 13G beneficial ownership disclosure with no stated intent, activism, or transaction beyond reporting the stake.

Market effects

Minimal, since the disclosure does not include operational or strategic changes.

None indicated.

None indicated.

Counterpoint

A 5.01% stake may be passive index or fund exposure rather than a directional bet, reducing any trading signal.

Key entities

  • Enova International Inc.

    Subject of the Schedule 13G beneficial ownership disclosure, with Vanguard reporting 5.01% ownership.

  • Vanguard Capital Management

    Filed the Schedule 13G reporting sole voting and dispositive power details for the reported stake.

  • SEC Schedule 13G

    Disclosure form used for beneficial ownership reporting, typically associated with passive intent.

Related articles

$OPFIMed

OppFi and Enova Bank Deals Put Lending Under Scrutiny

Attorneys general asked the Federal Reserve, OCC and FDIC to deny banking privileges tied to OppFi’s $130M acquisition of BNCCORP and BNC National Bank and Enova’s proposed acquisition of Grasshopper Bancorp and Grasshopper Bank. AGs allege bank partnerships bypass state loan-rate caps and cite high rates and charge-offs. OppFi and Enova project deposit and revenue synergies and EPS accretion.

$ENVAMed

ENVA Rallies As Enova Tops Q2 And Targets Grasshopper Bank Synergies

Enova International Inc. (NYSE: ENVA) shares rose about 9% after Q2 results and guidance-related optimism. The company reported adjusted EPS of $4.31 vs $3.96 consensus and revenue of $928.9M vs $764M prior year, with operating cash flow of $544M and $531.4M free cash flow. Analysts reportedly raised price targets to $257-$280, citing the Grasshopper Bank acquisition and improving credit metrics.

$ENVAMedAI 8/10

Enova International Stock Jumps After Powerful Q2 Beat

Enova International Inc. (NYSE: ENVA) shares rose about 9% during the week after the company reported Q2 2026 results and raised guidance. Adjusted EPS was $4.31 versus $3.96 expected, with revenue up to $928.9M from $764M. Management cited record $5.5B loans, improving margins, and ongoing share repurchases.

$ENVAMed

ENVA Jumps As Enova Earnings Beat Fuels Bullish Targets

Enova International Inc. (NYSE: ENVA) shares rose about 9% after its Q2 2026 results. The company reported adjusted EPS of $4.31 versus $3.23 a year earlier and revenue of $928.9M versus $764M, alongside a consumer credit outlook. Analysts cited bullish targets of $257 to $280 and support near $230.

$ENVAMedAI 8/10

Enova International Signals Strong Growth and Rising EPS

Enova International (ENVA) reported Q2 results and said consolidated originations rose 27% YoY to nearly $2.3B and total revenue rose 22% to $929M. Adjusted EPS increased 33% YoY to $4.31. Credit metrics improved, with net charge-offs at 7.3%. Management raised Q3 and 2026 guidance and noted the pending Grasshopper Bank deal awaits regulatory approval.

$ENVAMedAI 8/10

Enova Reports Second Quarter 2026 Results

Enova International (NYSE: ENVA) reported Q2 2026 results. Total revenue rose 22% to $929 million. Diluted EPS was $4.00, up 40%, and adjusted EPS was $4.31, up 33%. Credit metrics stayed strong, with net charge-offs at a 7.3% ratio and net revenue margin at 61%. Enova also repurchased $19 million of stock and reported $929 million liquidity at June 30.